Bill C-13, the COVID-19 Emergency Response Act, was the Canadian government’s legislative response to the Coronavirus pandemic. In addition a host of economic measures, the bill included some unexpected patent law provisions designed to speed access to essential medicines, devices or treatments. Matthew Herder, the director of the Health Law Institute at Dalhousie University, joins the podcast discuss the new Canadian rules, the use of compulsory licensing to enhance access to medicines, and other innovative approaches to overcoming potential access barriers raised by intellectual property laws.
Recent Posts
Back-of-the-Napkin Cultural Policy: The Government’s $600 Million Streaming Plan Copies the CRTC Decision It Killed at More Than Double the Cost 
The Law Bytes Podcast, Episode 282: Udbhav Tiwari on Why Signal May Exit Canada Over Bill C-22’s Encryption and Metadata Retention Rules 
From Making Web Giants Pay to Paying Media Giants: Budget 2026 Replaces the Government’s Internet Platform Strategy With $1.5 Billion in Taxpayer Dollars for Culture and News 
Has the Government Read Its Own Bill? What Three Days of House Debate Revealed About Bill C-34 Before the Committee Hearings Begin 
Surveillance By Design: Government Officials Say Lawful Access Could Reach Gaming Platforms, Daycares and AI Services
